Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

AVERTEST, LLC

NPI: 1083024061 · SAINT LOUIS, MO 63134 · Substance Use Disorder Rehabilitation Clinic/Center · NPI assigned 04/30/2014

$7.94M
Total Medicaid Paid
186,273
Total Claims
53,827
Beneficiaries
3
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHERZOG, JASON (CHIEF EXECUTIVE OFFICER)
NPI Enumeration Date04/30/2014

Related Entities

Other providers sharing the same authorized official: HERZOG, JASON

ProviderCityStateTotal Paid
HOLON HEALTH GREAT LAKES PC RICHMOND VA $321K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 27,617 $797K
2019 30,581 $1.17M
2020 31,474 $1.73M
2021 20,541 $973K
2022 33,175 $1.26M
2023 27,549 $1.30M
2024 15,336 $717K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 131,051 37,321 $6.40M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 18,415 9,194 $942K
82075 36,807 7,312 $599K